By Matt Grossman

Abbott Laboratories Wednesday raised its full-year adjusted-earnings guidance, after revenue from Covid-19 testing helped lift its diagnostics business sales 48% in the third quarter.

The Abbott Park, Ill.-based medical-products company forecast adjusted earnings per share of $5.00 to $5.10 for the year. In July, Abbott was guiding for per-share adjusted earnings of $4.30 a share to $4.50 a share.

Analysts had expected full-year adjusted earnings of $4.46 a share, according to FactSet.

Write to Matt Grossman at matt.grossman@wsj.com

(END) Dow Jones Newswires

October 20, 2021 08:02 ET (12:02 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Abbott Laboratories Charts.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Abbott Laboratories Charts.